Statins reduce pneumonia death rates
According to a new study conducted by British scientists, taking statins, which are used to decrease cholesterol level in blood, can prevent people dying from pneumonia.
08.04.2011 First International Congress of Euro-Asian Association of Dermatovenereologists
took place on March 25-26, 2011 in Kiev
24.03.2011 Together against allergy!
It was the motto of the meeting of Kharkov medical society of immunologists and allergologists, which took place on March 16, 2011.
Specialist discovered protein responsible for excessive blood clotting
Preparations that regulate cholesterol levels in blood also help decrease the risk of formation of dangerous clots of blood.
Statins will substitute antibiotics in treatment of numerous infections
Scientists from University of Edinburgh have found...
04.03.2011 Dear Women!
Our sincere and warm-hearted greetings on this beautiful spring holiday of the 8th of March! We wish you sound health, new professional achievements and high respect of men! Let each your day be sunny and full of joy, let love and harmony be always around you, let flowers bloom and music play in your honor. Be always smiling, full of hopes and optimism!
Scientists have proved that medicines do not work if you do not believe in their effectiveness
Researches from Oxbridge and two German universities after studying the role of conscious thinking in appreciation of pain have come to a conclusion that positive thinking double analgetic action while negative one may level this effect.
22.02.2011 Antibacterial therapy in the practice of dermatovenereologist
Nowadays it is hard to imagine practical activity of dermatovenereologist without antibacterial therapy.
25.01.2011 Company Ananta Medicare – Let’s help children together
From November 1, 2010 to January 31, 2011 our Company carries out a charitable action for children’s homes of Ukraine “Share your smile”.
Scientists work on creation of the vaccine against antibiotic-resistant Staphylococcus aureus
American specialists from Medical Centre of Rochester University have made an important step on the way to develop a vaccine against methicillin-resistant Staphylococcus aureus (MRSA) - Staphylococcus species resistant to the action of most known antibiotics, which makes treatment of the diseases induced by this bacterium impossible.